Back to search

University of British Columbia

A study of the contemporary atrial fibrillation epidemiology and oral anticoagulation in British Columbia : a population based study

Abstract

dc:description

Background: Atrial fibrillation (AF) is the most common sustained arrhythmia with an estimated prevalence between 1-3%. There is a paucity of research studying the contemporary AF epidemiology and novel stroke prophylaxis pharmaceuticals for AF in Western Canada. Starting in 2011, the first direct oral anticoagulant (DOAC) drugs were approved in Canada. This thesis identifies and describes British Columbia’s (BC) AF population then explores epidemiological trends and differences in AF including incidence, prevalence, treatment preferences, and outcomes. Furthermore, age and sex differences are investigated in each endpoint to identify potential health inequalities. Methods: This study linked administrative healthcare databases to identify the AF population in BC from 2008 to 2016. Patient characteristics were defined at date of AF diagnosis. Clinical endpoints following AF diagnosis included hospital admission, use and type of oral anticoagulants (OAC), and adverse outcomes. Analyses were stratified by age and sex. Results: The incidence of AF remains stable throughout the study window at approximately 0.43% per year (431/100,000 in 2016). The prevalence of AF grew from 2.2% in 2008 to 3.2% in 2016 with provincial demographics shifting towards an older population. The rate of OAC use following incident AF diagnosis was sub-optimal; among patients guideline indicated for OAC, 45.9% received OAC within 100 days of diagnosis. Temporal trends were observed in first OAC; DOACs grew to approximately 65% of all initial OAC prescriptions by 2016. Apixaban and rivaroxaban were associated with lower risk of composite events (mortality, stroke, and heart failure) than warfarin (adjusted hazard ratios 0.75 (0.66, 0.86) and 0.77 (0.70, 0.86), respectively). By 2016, the sex difference in OAC use had disappeared and outcomes were comparable. Rates of incidence, prevalence, OAC use, and outcomes are strongly associated with age. Conclusions: The burden of AF is growing in BC; the population is shifting to an older, more at risk population. The broadened armamentarium of OAC agents available is being utilized and is associated with improved outcomes. The epidemiology of AF, the treatment, and outcomes of patients differ by age and sex; therefore, future research should account for age and sex differences through appropriate methodology.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Population and Public Health
Grantor dc:publisher
University of British Columbia
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Daniele, Patrick

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/73809

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Daniele, Patrick. A study of the contemporary atrial fibrillation epidemiology and oral anticoagulation in British Columbia : a population based study. master's thesis, University of British Columbia, 2020. http://hdl.handle.net/2429/73809